Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study

Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study

Abstract Background As a secreted adipokine, adipsin has been recently shown to play a pivotal role in metabolic disorders. However, information regarding the association of circulating adipsin with non-alcoholic fatty liver disease (NAFLD) in humans is scant. Methods We recruited 1163 obese adult s...

Full description

Bibliographic Details
Main Authors:	Jinhua Zhang, Kangli Li, Lingling Pan, Fei Teng, Peizhen Zhang, Bingquan Lin, Youwen Yuan, Xueyun Wei, Wenyuan Li, Huijie Zhang
Format:	Article
Language:	English
Published:	BMC 2021-03-01
Series:	BMC Gastroenterology
Subjects:	Adipsin Non-alcoholic fatty liver disease Obesity Metabolic syndrome
Online Access:	https://doi.org/10.1186/s12876-021-01721-9

Similar Items

Adiposity Measurements and Metabolic Syndrome Are Linked Through Circulating Neuregulin 4 and Adipsin Levels in Obese Adults
by: Dan Guo, et al.
Published: (2021-05-01)

Korelasi persentase lemak tubuh dengan kadar adipsin pada premenopause
by: Rahmani Welan, et al.
Published: (2018-01-01)

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
by: Tafere GG, et al.
Published: (2020-05-01)

Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
by: Nicole Aaron, et al.
Published: (2021-06-01)

Regulation of Adipsin Expression by Endoplasmic Reticulum Stress in Adipocytes
by: Ka-Young Ryu, et al.
Published: (2020-02-01)

Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy
by: Min Liu, et al.
Published: (2021-10-01)

Comparison of the Effect of 8 weeks Concurrent Training and Green Coffee Supplementation on Serum Adipsin and Insulin Resistance in Obese Women
by: L Naderi, et al.
Published: (2017-12-01)

Potency measurements of the complement system facilitated by antibodies targeting the zymogen form of complement factor D (Adipsin)
by: Hansen, S.W.K, et al.
Published: (2022)

The effects of Combine Training Program on Level Adipsin and Insulin Resistance in Female Multiple Sclerosis Patients (MS)
by: zahra Raisi, et al.
Published: (2021-03-01)

Adipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction
by: Masahiro Mizuno, et al.
Published: (2021-08-01)

Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer–Simons syndrome)
by: Fernando Corvillo, et al.
Published: (2021-06-01)

Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study
by: Dan Guo, et al.
Published: (2019-10-01)

Correlation of CCL18 with Levels of Adi-pokines in the Sera of Patients with Myocardial Infarction in a 6-Month Period: Case Series
by: Atefeh GamarTalepoor, et al.
Published: (2020-07-01)

Reciprocal changes of serum adispin and visfatin levels in patients with type 2 diabetes after an overnight fast
by: Ioannis Legakis, et al.

Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women
by: Kristina Linder, et al.
Published: (2004-01-01)

Classification between normal and tumor tissues based on the pair-wise gene expression ratio
by: Wong YC, et al.
Published: (2004-10-01)

Predictors of HbA1c among Adipocytokine Biomarkers in African-American Men with Varied Glucose Tolerance
by: Elena Barengolts, et al.
Published: (2020-11-01)

Obesity and nonalcoholic fatty liver disease: current perspectives
by: Sarwar R, et al.
Published: (2018-09-01)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
by: Li Y, et al.
Published: (2021-05-01)

Features of nonalcoholic fatty liver disease pharmacotherapy in patients with overweight and obesity
by: K. V. Pivtorak
Published: (2017-08-01)

Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Abolghasem Hadinia, et al.
Published: (2019-12-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

Genetic predisposition in nonalcoholic fatty liver disease
by: Silvia Sookoian, et al.
Published: (2017-03-01)

Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease
by: Hae Yoon Choi, et al.
Published: (2013-02-01)

Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet.
by: G Shillabeer, et al.
Published: (1992-01-01)

Leptin in nonalcoholic fatty liver disease
by: Billur Canbakan, et al.
Published: (2008-07-01)

Adipsin Concentrations Are Associated with Back Pain Independently of Adiposity in Overweight or Obese Adults
by: Sharmayne R. E. Brady, et al.
Published: (2018-02-01)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
by: Dae Ho Lee
Published: (2020-06-01)

A clinical study of pulmonary function changes in patients with nonalcoholic fatty liver disease
by: CHEN Zhihui, et al.
Published: (2018-04-01)

Fat-Produced Adipsin Regulates Inflammatory Arthritis
by: Yongjia Li, et al.
Published: (2019-06-01)

The Protective Effect of <i>Myristica fragrans Houtt. </i>Extracts Against Obesity and Inflammation by Regulating Free Fatty Acids Metabolism in Nonalcoholic Fatty Liver Disease
by: Wenyu Zhao, et al.
Published: (2020-08-01)

Leptin resistance in patients with nonalcoholic fatty liver disease associated with obesity and overweight
by: M. A. Livzan, et al.
Published: (2015-12-01)

Obesity as a risk factor for nonalcoholic fatty liver disease. Approaches to correction of overweight and obesity
by: I. A. Nesina, et al.
Published: (2014-12-01)

Anthropometric studies of patients with nonalcoholic fatty liver disease
by: K. V. Pivtorak
Published: (2017-10-01)

Effect of silibinin on liver aminotransferases in patients with nonalcoholic fatty liver disease: A meta-analysis
by: CHANG Yue, et al.
Published: (2019-05-01)

Nonalcoholic fatty liver disease associated with obesity: the potential of essential phospholipids
by: D. I. Trukhan
Published: (2016-12-01)

Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study
by: Min-Kyung Lee, et al.
Published: (2015-12-01)

Multiprobiotic therapy from childhood prevents the development of nonalcoholic fatty liver disease in adult monosodium glutamate-induced obese rats
by: Kondro Maryana, et al.
Published: (2014-12-01)

Transaminases and gamma glutamyl transpeptidase for detecting nonalcoholic steatohepatitis and fibrosis in nonalcoholic fatty liver disease
by: Shahinul Alam, et al.
Published: (2016-07-01)

The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
by: Marina Nati, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_voejjvlod2obb2e3aatt0is6ch